Abstract
Infusion related adverse events (AE) with day 1 rituximab in patients with B-cell non-Hodgkin's lymphoma (NHL) are common. The purpose of this study was to evaluate the AE occurring in patients with malignant B-cell lymphocytosis who received rituximab. Patients with a > or = 3 x 10(9)/L absolute lymphocyte count (ALC) receiving rituximab from 1998 to 1999 or participating in a phase I study of rituximab and interleukin-12 were reviewed. The AE occurring on the day of rituximab, the treatment provided (including hospitalization), and the subsequent ALC responses were recorded. Twenty-seven patients were identified; 14 had NHL, one Waldenstrom's macroglobulinemia, and 12 patients had chronic lymphocytic leukemia. The baseline median ALC was 9.58 x 10(9)/L (mean, 49.31; range, 3.56-380.95). All patients received rituximab as an outpatient. There were only two AE > or = grade 3. One patient was hospitalized for 1 day for i.v. fluids to treat an increase in creatinine that occurred with tumor lysis. A second patient developed a pulmonary syndrome five days after day 1 rituximab and required mechanical ventilation, but had no long-term lung toxicity. This study demonstrates that patients with high numbers of circulating blood B-lymp...Continue Reading
Citations
Sep 26, 2002·Pharmacoepidemiology and Drug Safety
Jun 8, 2011·Annals of Hematology·Yu-Chung HuangCheng-Hwai Tzeng
Apr 30, 2003·Seminars in Oncology·Morie A GertzSteven P Treon
Mar 2, 2011·Cancer Biotherapy & Radiopharmaceuticals·Robert O Dillman
Jul 26, 2011·International Journal of Nursing Practice·Dora S P LangAlan Pearson
Dec 18, 2009·Anti-cancer Drugs·Maajid Mumtaz PeerzadaHamed A Daw
Feb 22, 2008·Clinical and Experimental Nephrology·Aisha ShaikhNelson Leung
May 21, 2009·Leukemia & Lymphoma·Dimitrios KalkanisIzidore S Lossos
Sep 17, 2004·Leukemia & Lymphoma·Morie A GertzPhilip R Greipp
Oct 30, 2004·Leukemia & Lymphoma·Doru T AlexandrescuPeter H Wiernik
Sep 18, 2008·Leukemia & Lymphoma·Xin LiuJunning Cao
Sep 13, 2006·Leukemia & Lymphoma·M MianR Greil
Apr 28, 2006·Clinical Lymphoma & Myeloma·Yair HerishanuElizabeth Naparstek
Apr 22, 2008·Joint, Bone, Spine : Revue Du Rhumatisme·Huguette Lioté
Aug 15, 2009·Pediatric Pulmonology·Martin BitzanLucy Carpineta
Apr 20, 2011·Journal of Clinical Pharmacy and Therapeutics·P Bose, O Qubaiah
Mar 20, 2013·Journal of Clinical Pharmacy and Therapeutics·Yongkang WuYu Wu
Aug 2, 2005·Cancer Treatment Reviews·Eva Kimby
Mar 17, 2010·Pediatric Pulmonology·Huguette LiotéFrédéric Lioté
Apr 16, 2015·American Journal of Clinical Pathology·Xueya ZhangJingxin Pan
Aug 24, 2006·Expert Review of Anticancer Therapy·Gerhard HeldMichael Pfreundschuh
Jan 23, 2015·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Frederico F SouzaNikhil Ramaiya
Jan 8, 2018·Chinese Neurosurgical Journal·Yuchen WuYuanbo Liu
Jul 22, 2018·Annals of Hematology·Kimberly KeeferAndry Van de Louw